Fundraising Fox
🦊/People
Sign in

Mark Mullikin

Executive at Vedanta Biosciences

Greater Boston

Find your path to Mark

22 people in our graph share verified history with Mark — schools, employers, funds. One of them is your warm intro.

Kevin BittermanunlockedMark: together at Editas Medicine (2016–2018)
×4Mark: together at Editas Medicine
×7Mark: together at Vedanta Biosciences

Executive at Vedanta Biosciences

Intro paths

→

In turn, Mark can intro founders to Vedanta Biosciences's investors below.

Vedanta Biosciences's investors · 8

AMR Action FundBoston · since 2023BNP ParibasBNP Paribas Asset Management EuropeParisGlobal Health Investment FundNew York · since 2023K2 HealthVenturesBoston · $10M – $100M checksSalica InvestmentsLondonSeventure PartnersParisTullisPalm Beach Gardens · since 2023

Co-founders at Vedanta Biosciences

BOBernat Olle
Bernat OlleExecutive Officer, Director

Experience

  1. Ensem TherapeuticsChief Financial Officercurrent2025 — present
  2. Value Creation PartnersManaging Partnercurrent2025 — present
  3. Value Creation PartnersChief Financial Officercurrent2025 — present
  4. Vedanta Biosciences, Inc.Chief Financial Officer2021 — 2025Greater Boston Area
  5. Editas MedicineVice President, Finance & Investor Relations2019 — 2020Greater Boston Area
  6. Editas MedicineSenior Director, Finance & Investor Relations2016 — 2019Greater Boston Area

Skills & more

LifesciencesFinancial Modeling

From Mark's professional profile.

Frequently asked questions

Who is Mark Mullikin?
Executive Officer at Vedanta Biosciences
Where does Mark Mullikin work?
Mark Mullikin is Executive at Vedanta Biosciences.
Where did Mark Mullikin go to school?
Mark Mullikin studied at MIT Sloan School of Management (MBA, Finance & Accounting); University of Chicago (BA, Economics).

Same school

Shared employers